ClinConnect ClinConnect Logo
Search / Trial NCT06888700

Project on TDCS Intervention to Enhance Advanced Social Cognitive Functions in Drug Rehabilitation Individuals

Launched by SHAANXI NORMAL UNIVERSITY · Mar 16, 2025

Trial Information

Current as of April 30, 2025

Enrolling by invitation

Keywords

Heroin Advanced Social Cognitive Function

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age between 30 and 60 years;
  • fulfilling the diagnostic criteria for severe substance use disorder as specified in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders.
  • a history of heroin use exceeding ten years, with a daily average intake of at least 0.1 grams.
  • abstinence duration of eight months or less, with a positive result of a urine test before entering the rehabilitation center.
  • no history of neuromodulation treatments such as tDCS within the past six months.
  • Exclusion Criteria:
  • a history of alcohol dependence, neurological disorders, or other complex psychiatric conditions.
  • the presence of intracranial metallic implants or elevated intracranial pressure.
  • a history of epilepsy or recent electroencephalogram evidence of epileptiform activity.
  • the use of implanted electronic devices, such as pacemakers;.
  • scalp hyperalgesia or a tendency toward bleeding.
  • severe cardiac conditions.

About Shaanxi Normal University

Shaanxi Normal University is a distinguished academic institution located in Xi'an, China, renowned for its commitment to advancing education and research in various fields, including the health sciences. The university actively engages in clinical research initiatives aimed at addressing pressing healthcare challenges through innovative methodologies and interdisciplinary collaboration. By fostering partnerships with healthcare professionals and leveraging its robust academic resources, Shaanxi Normal University strives to contribute to the development of evidence-based medical practices and improve patient outcomes in the community and beyond.

Locations

Xi'an, Shaanxi, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported